The retinal vessel filling time of 10 patients with early nonproliferative diabetic retinography was measured by fluorescein angiography. Initially, the reproduc ibility of the authors' standardized fluorescein angiography was assessed by control angiograms on two different dates in each patient. Thereafter, prolonged use (six months) of isoxsuprine sustained release (80 mg/day) led to a nearly 50 % reduction of the arterial filling time and a nearly 25 % reduction of the arteriove nous filling time, whereas no changes were seen in control patients.
This effect of isoxsuprine might be explained by an increase of red cell deformability and, concomitantly, a decrease of platelet adherence in the micro circulation of patients with diabetic mellitus.
Get full access to this article
View all access options for this article.
References
1.
Ballard DJ, Melton LJ, Dwyer MS, et al: Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota. Diabetes Care9:334-342, 1986.
2.
Burger W., Hövener G., Düsterhus R., et al: Prevalence and development of retinopathy in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus. A longitudinal study. Diabetol29:17-22, 1986.
3.
Haut J., Redor JY, Abboud E., et al: Classification of diabetic retinopathy. Ophthalmol195:145-155, 1987.
4.
Browning DJ, Flynn HW, Blankenship GW: Asymmetric retinopathy in patients with diabetes mellitus. Am J Ophthalmol105:584-589, 1988.
5.
Hoare EM, Barnes AJ, Dormany JA: Abnormal blood viscosity in diabetes mellitus and retinopathy. Biorheol13:21-25, 1976.
6.
Schmid-Schönbein H., Volger E.: Red-Cell aggrgation and red-cell deformability in diabetes. Diabetes25:897-902, 1976.
7.
Van Haeringen NJ, Oosterhuis JA, Terpstra J., et al: Erythrocyte aggregation in relation to diabetic retinopathy. Diabetol9:20-24, 1973.
8.
Aarts Pamm, Banga JD, Van Houwelingen BC, et al: Increased red blood cell deformability due to isoxsuprine administration decreases platelet adherence in a perfusion chamber: A double-blind cross-over study in patients with intermittent claudication. Blood67:1474-1481, 1986.
9.
Aarts Pamm, Heethaar RM, Sixma JJ: Red blood cell deformability influences platelets-vessel wall interaction in flowing blood. Blood64:1228-1233, 1984 .
10.
Bode WA, Fonk T., Van der Veen EA, et al: Effects of long-term treatment with isoxsuprine on the blood viscosity profile in maturity-onset diabetics. Clin Hemorheol2:189-193, 1982.
11.
Laux U.: Standardisierte fluorescein-injektion zur serien angiographie. Graefe'sArch Clin Exp Ophthalmol198: 57-62, 1976.
12.
Siegel, S.: Nonparametric Statistics for the Behavioral Sciences. Tokyo: McGraw-Hill kogakusha, Ltd., 1956, pp 116-127.
13.
Archer D., Krill AE, Newell FW: Fluorescein studies of normal choroidal circulation. Am J Ophthalmol69:543-554,1970.
14.
Oosterhuis JA, Boen-Tan TN: Choroidal fluorescence in the normal human eye. Ophthalmol162:246-260, 1971.
15.
Lieb WA, Bielefeld G.: Anatomie, Histologie und Physiologie der Endstromgefäse am augenhintergrund . Med Welt18: 472-478, 1967.
16.
Blair NP, Feke GT, Morales-Stoppello J., et al: Prolongation of the retinal mean circulation time in diabetes . Arch Ophthalmol100:764-768, 1982.
17.
Trope GE, Lowe Gdo, Ghafour IM, et al: Blood viscosity in proliferative diabetic retinopathy and complicated retinal vein trombosis. Trans Ophthalmol Soc UK103:108-110, 1983.
18.
Leiper JM, Lowe Gdo, Anderson J., et al: Effects of diabetic control and biosynthetic human insulin on blood rheology in established diabetics. Diabetes Res1:27-30, 1984.
